Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06579742 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
A NA study of Hair Thinning and Hair Loss, sponsored by Scale Media.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06579742: Active NA study of Hair Thinning and Hair Loss, sponsored by Scale Media.
NCT06579742 is a NA study of Hair Thinning and Hair Loss that is active but no longer recruiting, run by Scale Media. The registered enrollment target is 50 participants, below the 61-participant average among 10 other Hair Thinning trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06579742, a NA study of Hair Thinning and Hair Loss, is active but no longer recruiting, sponsored by Scale Media.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair thinning and shedding. The trial will last for 24 weeks and includes the completion of questionnaires and photo submissions at specific time points.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Live Conscious Beyond Collagen
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the registry record for NCT06579742 still lists
NCT06579742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 61-participant average among 10 other Hair Thinning trials with a reported enrollment target (18% lower).
The record links to 2 conditions, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06579742 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06579742 about?
NCT06579742 is a clinical study titled "A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin". This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair th...
What is the current status of trial NCT06579742?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-06-07. Estimated completion is 2024-12-31.
What conditions does trial NCT06579742 study?
This clinical trial studies the following conditions: Hair Thinning, Hair Loss.
What interventions are being tested in trial NCT06579742?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Live Conscious Beyond Collagen (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06579742?
This trial is sponsored by Scale Media, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06579742 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Thinning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06579742's enrollment target sits among peer trials
50 6th of 10 higher than 5 of 10 other Hair Thinning trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Thinning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
ACTIVE NOT RECRUITING · NA
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI